- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06112418
En randomiserad jämförelse av personlig vård baserad på hjärtsjukdomsstadieindelning kontra vanlig vård för att förebygga händelser (TRANSFORM)
En randomiserad jämförelse av personlig vård baserad på stadieindelning av kranskärlssjukdom kontra vanlig vård för primärt förebyggande av kardiovaskulära händelser
TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Cardiovascular disease (CVD) persists as the leading cause of morbidity and mortality worldwide at high societal cost. The current primary CVD prevention strategy relies upon risk stratification using population health markers such as age, sex, diabetes, hypertension, dyslipidemia and tobacco use, with preventive therapy intensified in higher risk strata. Since these risk factors are indirect surrogate markers of the underlying disease, atherosclerosis, this strategy leads to treatment of individuals with risk factors who do not have atherosclerosis and failure to treat those with significant atherosclerosis who lack risk factors. The current strategy also cannot determine which individuals are inadequately treated despite effective risk factor management (residual risk). With the current approach, the CV death rate is trending upward in the US despite evidence that screening asymptomatic patients reduces CV events and the widespread availability of effective preventive therapies.
This randomized, controlled, pragmatic trial is designed to address the unmet need for better strategies to identify asymptomatic individuals at increased risk for CV events due to atherosclerosis and to personalize their treatment based on CV risk estimates using coronary artery disease (CAD) visualization and quantification.
This study enrolls patients without known symptoms of ASCVD but who are at increased risk for ASCVD due to their age and having diabetes, prediabetes or metabolic syndrome and tests the hypothesis that a CAD Staging System-based care strategy reduces CV events compared with risk factor-based care. The Cleerly CAD Staging System incorporates imaging-based evaluation for coronary atherosclerosis, algorithm-supported pharmacotherapy and personalized education about their CAD.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Ryann Sardinia
- Telefonnummer: 7207398191
- E-post: ryann.sardinia@cleerlyhealth.com
Studera Kontakt Backup
- Namn: Ashley Dunham, PhD
- Telefonnummer: 7207398191
- E-post: ashley.dunham@cleerlyhealth.com
Studieorter
-
-
Arizona
-
Chandler, Arizona, Förenta staterna, 85224
- Rekrytering
- Chandler Clinical Trials
-
Kontakt:
- Muhammad Salim, MD
-
Scottsdale, Arizona, Förenta staterna, 85260
- Rekrytering
- Scottsdale Clinical Trials
-
Kontakt:
- Todd Dreitzler, MD
-
Sun City, Arizona, Förenta staterna, 85381
- Rekrytering
- Sun City Research
-
Kontakt:
- Juan Rodriguez, MD
-
Tucson, Arizona, Förenta staterna, 85704
- Rekrytering
- Noble Clinical Research
-
Kontakt:
- Roxana Rodriguez, MD
-
-
California
-
Beverly Hills, California, Förenta staterna, 90210
- Rekrytering
- Cardiovascular Research Foundation of Southern California
-
Kontakt:
- Ronald P. Karlsberg, MD
-
Beverly Hills, California, Förenta staterna, 90211
- Rekrytering
- Amicis Research: Beverly Hills
-
Kontakt:
- Michael Levine, MD
-
Canoga Park, California, Förenta staterna, 91303
- Rekrytering
- Valiance Clinical Research - Canoga Park
-
Kontakt:
- Rami Shaarawy
-
Chula Vista, California, Förenta staterna, 91911
- Rekrytering
- Cardiovascular Institute of San Diego
-
Kontakt:
- Milind D. Parikh, MD
-
Granada Hills, California, Förenta staterna, 91324
- Rekrytering
- Amicis Research: Granada Hills
-
Kontakt:
- Pascal Dabel, MD
-
Huntington Park, California, Förenta staterna, 90255
- Rekrytering
- Valiance Clinical Research: Huntington Park
-
Kontakt:
- Philip Kim, MD
-
Indian Wells, California, Förenta staterna, 92210
- Rekrytering
- HALO Diagnostics
-
Kontakt:
- John F. Feller, MD
-
La Jolla, California, Förenta staterna, 92037
- Rekrytering
- Scripps Health
-
Kontakt:
- Elizabeth Epstein, MD
-
Lancaster, California, Förenta staterna, 93534
- Rekrytering
- Chemidox Clinical Trials
-
Kontakt:
- Pamela Dewar-DeSilva, MD
-
Loma Linda, California, Förenta staterna, 92354
- Rekrytering
- Loma Linda University Health
-
Kontakt:
- Purvi Parwani, MD
-
Long Beach, California, Förenta staterna, 90805
- Rekrytering
- Long Beach Research Institute
-
Kontakt:
- Ashley Duzik, MD
-
Monterey Park, California, Förenta staterna, 91754
- Rekrytering
- Ace Research Institute - Monterey Park
-
Kontakt:
- Yu-Hsiang Sam Lee, MD
-
Newhall, California, Förenta staterna, 91321
- Rekrytering
- Amicis Research: Newhall
-
Kontakt:
- Thuong Vo, MD
-
Northridge, California, Förenta staterna, 91324
- Rekrytering
- Ace Research Institute: Northridge
-
Kontakt:
- Richard Park, MD
-
Northridge, California, Förenta staterna, 91324
- Rekrytering
- Amicis Research: Northridge
-
Kontakt:
- Nana Barseghian, MD
-
Northridge, California, Förenta staterna, 91325
- Rekrytering
- Ace Research Institute: Northridge #2
-
Kontakt:
- William Y. Josephson, MD
-
Northridge, California, Förenta staterna, 91325
- Aktiv, inte rekryterande
- Northridge Clinical Trials
-
Orange, California, Förenta staterna, 92868
- Rekrytering
- University of California- Irvine
-
Kontakt:
- Ailin Barseghian El-Farra, MD
-
Palo Alto, California, Förenta staterna, 94304
- Rekrytering
- Stanford Health Care
-
Kontakt:
- Sandra Tsai, MD
-
Palo Alto, California, Förenta staterna, 94304
- Rekrytering
- VA Palo Alto
-
Kontakt:
- Shriram Nallamshetty, MD
-
San Fernando, California, Förenta staterna, 91306
- Rekrytering
- Amicis Research: San Fernando
-
Kontakt:
- Farid Yasharpour, MD
-
Tarzana, California, Förenta staterna, 91356
- Rekrytering
- Valiance Clinical Research - Tarzana
-
Kontakt:
- Harpreet Singh, MD
-
Torrance, California, Förenta staterna, 90502
- Rekrytering
- Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center
-
Kontakt:
- Suvasini Lakshmanan, MD
-
Valencia, California, Förenta staterna, 91355
- Rekrytering
- Amicis Research: Valencia
-
Kontakt:
- Dennis Lewis, MD
-
Valley Village, California, Förenta staterna, 91607
- Rekrytering
- Concierge Clinical Trials
-
Kontakt:
- Neal R. Cutler, MD
-
-
Colorado
-
Aurora, Colorado, Förenta staterna, 80045
- Rekrytering
- University of Colorado
-
Kontakt:
- Steve Simon
-
Huvudutredare:
- Steve Simon, MD
-
Denver, Colorado, Förenta staterna, 80218
- Rekrytering
- St. Josephs (Intermountain Healthcare)
-
Kontakt:
- Christopher Angus, MD
-
-
Florida
-
Boca Raton, Florida, Förenta staterna, 33434
- Rekrytering
- Flourish Medical Research
-
Kontakt:
- Michael Hafran, MD
-
Cross City, Florida, Förenta staterna, 32628
- Rekrytering
- Apex Research
-
Kontakt:
- Tamir Salmani, MD
-
Hialeah, Florida, Förenta staterna, 33012
- Rekrytering
- Evolution Research Center
-
Kontakt:
- Riquel Gonzalez, MD
-
Jacksonville, Florida, Förenta staterna, 32209
- Rekrytering
- UF Health Jacksonville
-
Kontakt:
- Luis Ortega Paz, MD
-
Miami, Florida, Förenta staterna, 33137
- Rekrytering
- BioPhase Research
-
Kontakt:
- Julie Cadet-Plassman, MD
-
Miami, Florida, Förenta staterna, 33135
- Rekrytering
- Fiel Wellness Clinical Research LLC
-
Kontakt:
- Osvaldo Caroma, MD
-
Miami, Florida, Förenta staterna, 33155
- Rekrytering
- United Clinical Research
-
Kontakt:
- Teresa B. Alfonso, MD
-
Kontakt:
- Alfonso
-
Miami, Florida, Förenta staterna, 33173
- Rekrytering
- Atlantis Clinical Research, LLC
-
Kontakt:
- Leyvi Alvarado Miranda, MD
-
Miami, Florida, Förenta staterna, 33183
- Rekrytering
- Farma Medical Inc.
-
Kontakt:
- Ingrid Fernandez-Milian, MD
-
Miami, Florida, Förenta staterna, 33173
- Rekrytering
- Baptist Health Miami Cardiac and Vascular Institute
-
Kontakt:
- Jonathan Fialkow, MD
-
Miami, Florida, Förenta staterna, 33186
- Rekrytering
- New Access Research and Medical Center
-
Kontakt:
- Sander Fernandez, MD
-
Miami Beach, Florida, Förenta staterna, 33140
- Rekrytering
- Quantum Clinical Trials
-
Kontakt:
- Christopher A. Fayeghi, MD
-
Pensacola, Florida, Förenta staterna, 32504
- Rekrytering
- Ascension Sacred Heart
-
Kontakt:
- Rohit Amin, MD
-
Pompano Beach, Florida, Förenta staterna, 33060
- Rekrytering
- Clinical Research Center of Florida
-
Kontakt:
- Howard S. Koch, MD
-
Tampa, Florida, Förenta staterna, 33620
- Rekrytering
- University of South Florida
-
Kontakt:
- Shone Almeida, MD
-
-
Georgia
-
Augusta, Georgia, Förenta staterna, 30907
- Rekrytering
- Aiyan Diabetes Center
-
Kontakt:
- Anthony D. Turner, MD
-
Dunwoody, Georgia, Förenta staterna, 30338
- Rekrytering
- Emory University
-
Kontakt:
- Ambar Kulshreshtha, MD
-
Fayetteville, Georgia, Förenta staterna, 30214
- Rekrytering
- Privia Medical Group Georgia LLC -Fayetteville (Javara)
-
Kontakt:
- Charlotte Grayson Mathis, MD
-
Lithia Springs, Georgia, Förenta staterna, 30122
- Rekrytering
- Randomize Now- Atlanta West
-
Kontakt:
- Millard Collier Jr., MD
-
Macon, Georgia, Förenta staterna, 31210
- Rekrytering
- Randomize Now-Burton Medical
-
Kontakt:
- Frederick Burton, MD
-
Norcross, Georgia, Förenta staterna, 30092
- Rekrytering
- Evergreen Clinical Trials
-
Kontakt:
- Dmitriy Pelishev, MD
-
Powder Springs, Georgia, Förenta staterna, 30127
- Rekrytering
- Peachtree Clinical Solutions - Noir Research Collective
-
Kontakt:
- Karan Raghavan, MD
-
Riverdale, Georgia, Förenta staterna, 30296
- Rekrytering
- Randomize Now, LLC - Noir Research Collective
-
Kontakt:
- Claire K. Willie, MD
-
Savannah, Georgia, Förenta staterna, 31406
- Rekrytering
- Privia Medical Group Georgia, LLC (Javara Inc.)
-
Kontakt:
- Thomas G. Moriarity, MD
-
Thomasville, Georgia, Förenta staterna, 31792
- Rekrytering
- Privia Medical Group Georgia - Thomasville (Javara)
-
Kontakt:
- William L. Cooper, MD
-
-
Idaho
-
Meridian, Idaho, Förenta staterna, 83642
- Rekrytering
- Care Institute- High Desert
-
Kontakt:
- David A. Hinchman, MD
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60611
- Rekrytering
- Northwestern University
-
Kontakt:
- Paul C. Cremer, MD
-
Glenview, Illinois, Förenta staterna, 60026
- Rekrytering
- Northshore University Health System
-
Kontakt:
- Amit K. Pursnani, MD
-
-
Indiana
-
Indianapolis, Indiana, Förenta staterna, 46237
- Rekrytering
- Franciscan Physician Network- Indiana Heart Physicians
-
Kontakt:
- Ryan P Daly, MD
-
Indianapolis, Indiana, Förenta staterna, 46202
- Rekrytering
- Indiana Medical Research Institute
-
Kontakt:
- Arshad P. Malik
-
-
Iowa
-
West Des Moines, Iowa, Förenta staterna, 50266
- Rekrytering
- MercyOne Iowa Heart Center
-
Kontakt:
- Enrico L. Martin, MD
-
-
Kentucky
-
Edgewood, Kentucky, Förenta staterna, 41017
- Rekrytering
- St Elizabeth Health Care - CRI
-
Kontakt:
- Erica Pivato, MD
-
Louisville, Kentucky, Förenta staterna, 40202
- Rekrytering
- UofL Health
-
Kontakt:
- Shahab Ghafghazi, MD
-
-
Louisiana
-
New Orleans, Louisiana, Förenta staterna, 70127
- Rekrytering
- Ascension DePaul Services Research Center
-
Kontakt:
- Kristen Thomas, MD
-
-
Maryland
-
Bowie, Maryland, Förenta staterna, 20715
- Rekrytering
- Flourish Bowie dba Flourish Research
-
Kontakt:
- Sara Collins, MD
-
Columbia, Maryland, Förenta staterna, 21045
- Rekrytering
- KUR Research at CMP
-
Kontakt:
- William Saway, MD
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02115
- Rekrytering
- Brigham and Women's Hospital
-
Kontakt:
- Ron Blankstein, MD
-
Boston, Massachusetts, Förenta staterna, 02114
- Rekrytering
- Massachusetts General Hospital
-
Kontakt:
- Pradeep Natarajan, MD
-
-
Michigan
-
Detroit, Michigan, Förenta staterna, 48202
- Rekrytering
- Henry Ford Hospital
-
Kontakt:
- Cori E Russell, MD
-
Ypsilanti, Michigan, Förenta staterna, 48917
- Rekrytering
- Trinity Health Michigan Heart
-
Kontakt:
- Ahmad Mizyed, MD
-
-
Minnesota
-
Minneapolis, Minnesota, Förenta staterna, 55407
- Rekrytering
- Minneapolis Heart Institute Foundation
-
Kontakt:
- Michael D. Miedema, MD
-
-
Missouri
-
St Louis, Missouri, Förenta staterna, 63110
- Rekrytering
- Washington University School of Medicine
-
Kontakt:
- Farhan M. Katchi, MD
-
St Louis, Missouri, Förenta staterna, 63136
- Rekrytering
- Saint Louis Heart and Vascular
-
Kontakt:
- Gil Vardi, MD
-
-
Montana
-
Kalispell, Montana, Förenta staterna, 59901
- Rekrytering
- Boeson Research Kalispell
-
Kontakt:
- Justin Buls, MD
-
Missoula, Montana, Förenta staterna, 59804
- Rekrytering
- Boeson Research Fort Missoula
-
Kontakt:
- Audrey Remmers, MD
-
-
Nebraska
-
Lincoln, Nebraska, Förenta staterna, 68506
- Rekrytering
- Bryan Heart
-
Kontakt:
- Chad E. Travers, MD
-
-
Nevada
-
Las Vegas, Nevada, Förenta staterna, 89128
- Rekrytering
- Vector Clinical Trials
-
Kontakt:
- Bharat R. Mocherla, MD
-
Las Vegas, Nevada, Förenta staterna, 89102
- Rekrytering
- Southwest Medical Associates- Optum Nevada
-
Kontakt:
- Tatiana O. Tsvetkova, MD
-
-
New Jersey
-
Flemington, New Jersey, Förenta staterna, 08822
- Rekrytering
- Advanced Heart and Vascular Institute of Hunterdon
-
Kontakt:
- Andrey Espinoza, MD
-
Marlton, New Jersey, Förenta staterna, 08053
- Rekrytering
- Virtua Health, Inc.
-
Kontakt:
- Mark T. Finch, MD
-
New Brunswick, New Jersey, Förenta staterna, 08901
- Rekrytering
- Rutgers State University
-
Kontakt:
- Sabahat Bokhari, MD
-
Paramus, New Jersey, Förenta staterna, 07652
- Rekrytering
- The Valley Hospital
-
Kontakt:
- Himanshu Gupta, MD
-
Teaneck, New Jersey, Förenta staterna, 07666
- Rekrytering
- Holy Name Medical Center
-
Kontakt:
- Jaffar Raza, MD
-
-
New York
-
Brooklyn, New York, Förenta staterna, 11221
- Rekrytering
- Clindove Research
-
Kontakt:
- Nelly Cohen, MD
-
Brooklyn, New York, Förenta staterna, 11226
- Rekrytering
- Swift Clinical Research
-
Kontakt:
- Manoj Dalmia, MD
-
Jackson Heights, New York, Förenta staterna, 11372
- Rekrytering
- Rasaj Research
-
Kontakt:
- Ammara Mushtaq, MD
-
Lake Success, New York, Förenta staterna, 11042
- Rekrytering
- Optum- Long Island NY
-
Kontakt:
- Steven Goldberg, MD
-
Mount Kisco, New York, Förenta staterna, 10549
- Rekrytering
- Northwell Health Northern Westchester Hospital
-
Kontakt:
- Margaret Andersen, MD
-
New York, New York, Förenta staterna, 10019
- Rekrytering
- Mount Sinai West
-
Kontakt:
- Waqas A Malick, MD
-
New York, New York, Förenta staterna, 10029
- Rekrytering
- Mount Sinai
-
Kontakt:
- Solomon Bienstock, MD
-
-
North Carolina
-
Chapel Hill, North Carolina, Förenta staterna, 27599
- Rekrytering
- University of North Carolina at Chapel Hill
-
Kontakt:
- Matthew Cavender, MD
-
Durham, North Carolina, Förenta staterna, 27701
- Rekrytering
- Duke University Hospital
-
Kontakt:
- William Yancy, MD
-
Durham, North Carolina, Förenta staterna, 27705
- Rekrytering
- Durham Veterans Affairs Medical Center (Durham VAMC)
-
Kontakt:
- Hayden Bosworth, MD
-
Fayetteville, North Carolina, Förenta staterna, 28304
- Rekrytering
- Cape Fear Valley Health System (Javara Inc.)
-
Kontakt:
- Nafisa Saleem, MD
-
Morehead City, North Carolina, Förenta staterna, 28557
- Aktiv, inte rekryterande
- West Clinical Research
-
Winston-Salem, North Carolina, Förenta staterna, 27157
- Rekrytering
- Wake Forest University Health Sciences
-
Kontakt:
- Michael Shapiro, MD
-
-
North Dakota
-
Fargo, North Dakota, Förenta staterna, 58102
- Rekrytering
- Sanford Health
-
Kontakt:
- David J. Clardy, MD
-
-
Ohio
-
Akron, Ohio, Förenta staterna, 44304
- Rekrytering
- Summa Health
-
Kontakt:
- Wissam Alajaji, MD
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Förenta staterna, 73109
- Rekrytering
- Medical Research International, LLC
-
Kontakt:
- Joseph Grillo, MD
-
Oklahoma City, Oklahoma, Förenta staterna, 73007
- Rekrytering
- Hightower Clinical
-
Kontakt:
- Faisal Latif, MD
-
Tulsa, Oklahoma, Förenta staterna, 74104
- Rekrytering
- Ascension St. John - Jane Phillips Medical Center
-
Kontakt:
- Michael Megaly, MD
-
-
Pennsylvania
-
Camp Hill, Pennsylvania, Förenta staterna, 17011
- Rekrytering
- Capital Area Research
-
Kontakt:
- Venkatesh Nadar, MD
-
-
South Carolina
-
Charleston, South Carolina, Förenta staterna, 29425
- Rekrytering
- Medical University of South Carolina
-
Kontakt:
- Marc-Andre Cornier, MD
-
-
Tennessee
-
Cleveland, Tennessee, Förenta staterna, 37312
- Rekrytering
- Community DPC
-
Kontakt:
- Carlton Volberg, MD
-
Knoxville, Tennessee, Förenta staterna, 37920
- Rekrytering
- University of Tennessee Medical Center
-
Kontakt:
- Kashif A. Shaikh, MD
-
Nashville, Tennessee, Förenta staterna, 37202
- Rekrytering
- TriStar Centennial Medical Center (HCA Health Care)
-
Kontakt:
- David Huneycutt, MD
-
-
Texas
-
Abilene, Texas, Förenta staterna, 79601
- Rekrytering
- Hendrick Health
-
Kontakt:
- Ren Zhang, MD
-
Beaumont, Texas, Förenta staterna, 77702
- Rekrytering
- Gadolin Research
-
Kontakt:
- John T Fowler, MD
-
Greenville, Texas, Förenta staterna, 75402
- Rekrytering
- CardioVoyage, LLC
-
Kontakt:
- Marc Demyun, MD
-
Houston, Texas, Förenta staterna, 77025
- Rekrytering
- Kelsey Research Foundation
-
Kontakt:
- Rohan R Wagle, MD
-
Houston, Texas, Förenta staterna, 77004
- Rekrytering
- Helium Research Group
-
Kontakt:
- Ijeoma A. Ekeruo
-
Houston, Texas, Förenta staterna, 77070
- Rekrytering
- Gulf Coast Clinical Research, LLC
-
Kontakt:
- Anjani Pandya, MD
-
Houston, Texas, Förenta staterna, 77030
- Rekrytering
- The Methodist Hospital, DeBakey Cardiology Associates
-
Kontakt:
- Sadeer Al-Kindi, MD
-
Laredo, Texas, Förenta staterna, 78041
- Rekrytering
- Aeres Clinical Research
-
Kontakt:
- Amando Garza, MD
-
Lewisville, Texas, Förenta staterna, 75057
- Rekrytering
- DC Clinical Research
-
Kontakt:
- Moiz M. Shafiq, MD
-
McKinney, Texas, Förenta staterna, 75069
- Rekrytering
- North Dallas Research Associates - Kerlo Network
-
Kontakt:
- Muhammad Akram Khan, MD
-
Mesquite, Texas, Förenta staterna, 75149
- Rekrytering
- SMS Clinical Research
-
Kontakt:
- Salma Saiger, MD
-
San Marcos, Texas, Förenta staterna, 78666
- Rekrytering
- Privia Medical Group Gulf Coast, PLLC ( Javara Inc.)
-
Kontakt:
- Alan Lee, MD
-
Stephenville, Texas, Förenta staterna, 76401
- Rekrytering
- Privia Medical Group- North Texas
-
Kontakt:
- Benjamin Marcum, MD
-
-
Utah
-
West Valley City, Utah, Förenta staterna, 84120
- Har inte rekryterat ännu
- Kalo Clinical Research
-
Kontakt:
- William J. Walsh, MD
-
-
Virginia
-
Richmond, Virginia, Förenta staterna, 23225
- Rekrytering
- Chippenham Johnston Willis Medical Center
-
Kontakt:
- Michael Arcarese, MD
-
-
Washington
-
Everett, Washington, Förenta staterna, 98201
- Rekrytering
- Providence Regional Medical Center Everett
-
Kontakt:
- Xiaojing Jennie Shen, MD
-
Seattle, Washington, Förenta staterna, 98195
- Rekrytering
- University of Washington
-
Kontakt:
- Kelley Branch, MD
-
-
West Virginia
-
Charleston, West Virginia, Förenta staterna, 25304
- Rekrytering
- Charleston Area Medical Center
-
Kontakt:
- Sarah Rinehart, MD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
Provided electronic or written informed consent
-
Men > 55, women > 65 years of age
-
Type 2 diabetes mellitus requiring pharmacologic therapy, prediabetes (most recent HbA1c 5.7 to 6.4% and/or fasting glucose 100-125 mg/dL [5.6-6.9 mmol/L]) and/or metabolic syndrome. Metabolic syndrome is defined as > 3 of the following criteria (International Diabetes Federation 2006):
- Body mass index ≥ 27 kg/m2 or abnormal waist circumference defined as ≥ 80 cm (31.5 inches) for women, ≥ 94 cm (37 inches) for men; for South and East Asian men (e.g., Asian Indian, Chinese, Japanese) ≥ 90 cm (35.4 inches)
- Fasting triglycerides ≥ 150 mg/dL (1.7 mmol/L) or treated hypertriglyceridemia
- HDL-cholesterol (HDL-C) < 40 mg/dL (1.03 mmol/L) in men, <50 mg/dL (1.29 mmol/L) in women or treatment for this lipid abnormality
- Systolic blood pressure (BP) ≥ 130 and/or diastolic BP≥ 85 mm Hg and/or treated hypertension
- Fasting blood glucose ≥ 100 mg/dL (5.6 mmol/L) or HbA1c ≥ 5.7%
-
Have a device (e.g., smartphone, tablet, computer) for communication with the central cardiologist-led team managing drug treatment for the personalized care group
Exclusion Criteria:
-
History of symptomatic CVD defined as prior MI, exertional or unstable angina, ischemic stroke, claudication, arterial revascularization for atherosclerosis or other CVD being actively managed by a cardiologist, e.g. atrial fibrillation, heart failure
-
Planned arterial revascularization
-
Inability to complete screening CCTA or any condition that would increase the risk associated with CCTA or increase likelihood of uninterpretable scan including:
- eGFR < 60 mL/min/1.73 m2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) or Modification of Diet in Renal Disease (MDRD) equation (www.kidney.org/professionals/kdoqi/gfr_calculator)
- Allergy to iodinated contrast or history of contrast-induced nephropathy (including adverse reaction to contrast at screening CCTA) or screening laboratory values consistent with untreated hyperthyroidism. Participants with elevated thyroid-stimulating hormone (TSH) may be enrolled but should be referred to their physician for evaluation for treatment.
- Thyroid cancer in the previous five (5) years or planned radioactive iodine treatment
- Weight > 300 lbs. (136 kg) or above manufacturer-recommended limit for scanner and table at the site
- Inability to hold breath for > 10 seconds
- Active arrhythmia (atrial fibrillation, atrial flutter, frequent premature atrial, or ventricular contractions) with poorly controlled rate (i.e., > 80 beats per minute at screening or prior to CCTA)
- Contraindication to dosing with beta blocker or nitroglycerin on day of screening CCTA
- Any other factor that, in the opinion of the investigator, would increase participant risk or increase the chance of an uninterpretable CCTA
-
Unsuitable as a trial participant in the opinion of the investigator for reasons including significant left main stenosis (e.g. ≥ 70%; site will be notified by Cleerly), other health condition with life expectancy < 3 years or being at risk of poor compliance with study procedures (e.g., active substance abuse or untreated mental illness that, in the opinion of the investigator, is likely to adversely affect adherence or retention)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Risk Factor-Based Care
The risk factor-based care group will be managed by their usual care providers, with an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. During the trial, the centralized cardiology team will monitor the provision of medications prescribed and lab values relative to guidelines, and provide feedback and education to site investigators to support optimization. CCTA results will be centrally archived and will remain blinded to the usual care provider until the end of the study. |
|
|
Experimentell: Cleerly Stage-Based Care
The Cleerly Stage-Based Care group will receive personalized care centrally managed by a remote cardiologist-led team. They will also receive an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. Cleerly CAD Staging System results will be discussed with participants and serve as the basis for standardized algorithm-supported pharmacotherapy & education, which will be intensified if plaque burden has progressed at 24 months. |
The Cleerly CAD Staging System is software that utilizes a proprietary algorithm to identify CAD, stage the severity of CAD when present, and generate a prognostic risk score to inform treatment decisions that support CV disease prevention. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The primary objective is to compare Cleerly stage-based care with risk factor-based care on the risk of CV events.
Tidsram: Through study completion- an average of 3.5 years
|
The primary endpoint is total (first and subsequent) events for the composite endpoint of CV death, myocardial infarction (MI), ischemic stroke, acute limb ischemia, clinically driven arterial revascularization, and hospitalization or urgent visit for heart failure. |
Through study completion- an average of 3.5 years
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsram: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to first occurence of an event in the primary efficacy endpoint. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsram: Through study completion- an average of 3.5 years
|
The secondary endpoints are total occurences after randomization of the primary efficacy endpoing, kidney failure, sustained estimated glomerular filtration rate (eGFR) decrease >40% from baseline, and death from renal causes. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsram: Through study completion- an average of 3.5 years
|
The secondary endpoints are first and total occurrences after randomization of coronary death, MI, and urgent coronary revascularization. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsram: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to first occurrence of MI or ischemic stroke. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsram: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to all-cause death. |
Through study completion- an average of 3.5 years
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The safety objective is to assess harm with the 2 prevention strategies
Tidsram: Through study completion- an average of 3.5 years
|
The safety endpoints are Adverse events (AE) leading to discontinuation of study-recommended medication (DAE), serious AE (SAE), adverse device effect (ADE). |
Through study completion- an average of 3.5 years
|
|
The safety objective is to assess harm with the 2 prevention strategies
Tidsram: Through study completion- an average of 3.5 years
|
The safety endpoints are 20-item Short Form survey (SF-20). |
Through study completion- an average of 3.5 years
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Studiestol: Deepak Bhatt, MD, MPH, Mt. Sinai Heart
- Studiestol: David J. Maron, MD, FASPC, Stanford University
Publikationer och användbara länkar
Allmänna publikationer
- Clerc OF, Fuchs TA, Stehli J, Benz DC, Grani C, Messerli M, Giannopoulos AA, Buechel RR, Luscher TF, Pazhenkottil AP, Kaufmann PA, Gaemperli O. Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials. Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):838-846. doi: 10.1093/ehjci/jey014.
- Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 202302CPC
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .